SCR-LIP-000379 · Claim · machine-readable JSON →

In 30 women with clinically confirmed lipedema undergoing 99mTc-nanocolloid lymphoscintigraphy, 60% showed no overt lymphatic damage while 40% showed confirmed lymphatic alterations indicating coexisting lipo-lymphedema, with lymphoscintigraphy used to detect lymphostatic components and guide surgical decisions rather than for routine lipedema diagnosis, which remains clinical.

Created: 2026-05-31 · Last updated: 2026-05-31

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

Evidence (1)

• DOI:10.4081/vl.2025.14438 — refines · case series · 2025
  Single-center case series evaluating lymphoscintigraphy's role in lipedema; it addresses imaging differentiation of lymphostatic involvement but concludes the test is not essential for diagnosis, refining the claim that such imaging definit

Context (PECO)

Answers these questions

• Can MRI, lymphoscintigraphy, or DXA differentiate lipedema from lymphedema and other fat distributions? refines

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log

• 2026-05-31 — created · auto-ingested for SQ-LIP-000023

← All claims